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Abstract
I In nt tr ro od du uc ct ti io on n: :   The epidemiology of human bocavirus (HBoV) infections has not
been described in Greece, a south-eastern European country. To define the
epidemiological profile and the clinical characteristics associated with HBoV
infection in a population of children hospitalized with respiratory tract infection. 
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: : During a one-year period throat swab samples were
collected from 370 previously healthy children, aged 14 days to 13 years, admitted
to two different paediatric wards because of respiratory tract infection. Samples
were tested for HBoV by PCR amplifying a part of the NS1 gene.
R Re es su ul lt ts s: : Human bocavirus was detected in 12 children (3.2%). Four of the 
12 cases were co-infections, 3 of them with influenza A and 1 with coronavirus
OC43. Cases were observed only during the cold months. The mean age of
children was 1.8 years (range 2 months to 4 years). The most common symptoms
were fever, cough and various degrees of respiratory distress. All children were
clinically  diagnosed  as  having  lower  respiratory  tract  infections,  mainly
pneumonia and acute laryngotracheobronchitis, and recovered uneventfully. 
C Co on nc cl lu us si io on ns s: : HBoV infections occur in Greece mostly among very young children.
They accounted for 3.2% of children hospitalized with acute respiratory disease.
Cases were observed only in late autumn to early spring.
K Ke ey y   w wo or rd ds s: :   respiratory infections, children, respiratory viruses, human bocavirus.
Introduction
Human bocavirus (HBoV) (genus Bocavirus, family Parvoviridae) has
been recently identified in children with respiratory tract infection (RTI),
first in Sweden [1], and subsequently in different parts of the world [2-10].
However, most studies so far have only retrospectively studied virus
prevalence and only a few have addressed whether HBoV infection is
associated with respiratory disease symptoms.
The aim of the present study was to define the epidemiological profile
and the clinical characteristics associated with HBoV in hospitalized
children with respiratory tract infection (RTI) in Greece.
Material and methods
During a one-year period (October 2006 to September 2007) throat
swab samples were collected from 370 previously healthy children, aged
14 days to 13 years (mean age ± SD 17 ±13 months) admitted to two dif-
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ferent large hospitals of Thessaloniki, Northern
Greece. Samples were taken on the first day of
admission and kept at –70°C until use. 
All children were admitted because of acute in-
fection of the respiratory tract. Demographic data
and clinical diagnosis including acute infection of
the  upper  respiratory  tract,  croup,  bronchitis,
bronchiolitis and pneumonia were obtained from
a computer-generated discharge diagnosis based
database. The case notes of children were reviewed
using a standardised clinical data extraction form.
The following data were recorded: sex, age, initial
presenting symptoms, signs, discharge diagnosis
and  routine  laboratory  examinations  upon
admission and during hospitalization (complete
blood count, C-reactive protein, chest X-ray). 
Extracted DNA was subjected to polymerase 
chain reaction (PCR) which targets the NS1 gene of
the  HBoV  genome  [8].  All  PCR  products  were
sequenced  and  nucleotide  sequences  were
compared with respective HBoV sequences retrieved
from GenBank. In addition, all samples were tested
by molecular methods for Mycoplasma pneumoniae,
respiratory syncytial virus, coronaviruses, influenza
viruses, human metapneumovirus and adenoviruses. 
Results
HBoV  DNA  was  detected  in  samples  of  12
children (3.3%), 6 of them males. Sequencing and
phylogenetic  analysis  revealed  that  HBoV
sequences of 11 cases were identical to each other
and to the Swedish strain st2 (NC007455), differing
by 1 nucleotide from the 12th case (GR186), which
was identical to strain CHSD4 (DQ471814) from USA. 
All cases had clinical evidence of lower RTI (fever,
tachypnoea, hypoxia, retractions, and abnormal
auscultation findings). Four of the 12 cases were co-
infections, 3 of them with influenza A virus and 
1 with coronavirus OC43. 
Concerning the 8 patients in whom only HBoV
was detected, they were 3 males and 5 girls, aged
2-33 months (mean age ± SD: 17 ±9 months),
hospitalized with the clinical diagnosis of 2 each:
laryngotracheobronchitis, bronchiolitis, pneumonia,
and asthma exacerbation. 
Common symptoms of viral respiratory tract
infection such as fever, cough, rhinorrhoea and
pharyngitis were found in the majority of our
patients (87.5-100%). Six patients (75%) presented
with various degrees of respiratory distress. Those
patients had tachypnoea (a respiratory rate of 
45-90 breaths/min) and low haemoglobin oxygen
saturation  levels  (SaO2)  in  the  range  90-94%. 
These children received oxygen supplementation
until 1 day before discharge. Wheezing was the
most common clinical finding (5 patients) while
another 1 child presented with stridor. Hoarseness
was noticed in 2 children. Difficulty in feeding was
also a common complaint, reported by 5 patients.
Other  clinical  findings  included  diarrhoea 
(2 patients, 25%), a symptom previously described
in  HBoV  infections  [11,  12],  and  otitis  media 
(1 patient, 12.5%). The major clinical and laboratory
findings in the 8 patients in whom HBoV was the
sole pathogen detected are presented in Table I.
Chest X-rays were available for all 8 children. The
most common finding, present in 6 patients, was
bilateral interstitial infiltrates. Consolidation was
detected in the other 2 children. 
Clinical expression was not different in children
with HBoV co-infection. The child with coronavirus
OC43 co-infection also presented with conjunctivi-
tis, while respiratory distress was the main concern
in a child with influenza-A virus co-infection. 
All children recovered uneventfully. The median
hospitalization time was 5 days (range 4-9 days).
For 1 patient a second throat swab sample, taken
20 days after the first one, was found negative for
HBoV DNA. 
B B. .   L La ab bo or ra at to or ry y   f fi in nd di in ng gs s M Me ea an n   ± ±   S SD D R Ra an ng ge e
White blood [cells/mm3] 13744 ±5441 3200-20 380
Granulocytes/mm3 8103 ±5245 480-15 672
Granulocytes % 53 ±25.6 15-77
Lymphocytes/mm3 3613  ±1657 921-5892
Lymphocytes  % 31.5  ±19.3 11.5-48.7
Haemoglobin [g/dl] 12.3  ±0.7 11.3-13.4
Platelet count/mm3 428 714  235 000-
±138 816 643 000
C-reactive protein [mg/dl] 2.9 ±2.8 0.1-6.75
Creatinine [mg/dl] 0.4 ±0.6 0.33-0.49
Na+ [mEq/l] 136.1 ±3.4 131.1-139.4
K+ [mEq/l] 3.9 ±0.9 3.6-4.8
SGOT [IU/l] 47.7 ±14.8 30-74
SGPT [IU/l] 33.4 ±23.9 17-81
A A. .   C Cl li in ni ic ca al l   f fi in nd di in ng gs s N No o. .   ( (% %) )
Cough 8 (100)
Rhinorrhoea/pharyngitis 7 (87.5)
Fever 7 (87.5)
Respiratory distress 6 (75)
Wheezing 5 (62.5)
Stridor 1 (12.5) 
Diarrhoea 2 (25)
Otitis media 1 (12.5)
T Ta ab bl le e   I I. . Clinical (A) and laboratory findings (B) in 8 patients in whom HBoV was the sole pathogen detected  
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Discussion
Prevalence of HBoV in our study (3.3%) was
found to be relatively low compared to published
data from other parts of the world [2, 4, 6, 9, 10, 
13-16]. However, prevalence rates between 1.5 and
19% have been observed and it is possible that dif-
ferences of study populations and sampling techni-
ques account for the encountered discrepancies
[17]. Although the number of studies since the first
description of HBoV is increasing, many of these
studies are retrospective on stored samples, or only
on samples negative for other pathogens, or on
samples collected during a few months and thus
suffering from the bias that sampling may be
guided from the occurrence of RSV or influenza
epidemics. In the present prospective study samples
were  collected  during  1  year and  were  tested
regardless of positivity for another pathogen. 
In previous whole year studies it was found that
the vast majority of HBoV positive samples were
collected in cold months [14, 18, 19]. We also found
that positive cases were observed only during the
cold months. The first HBoV case was observed in
mid December 2006, and the last at the end of April
2007. Greece is a Mediterranean country in the
Balkan Peninsula, with hot, dry summers and cold,
damp winters. Nevertheless, the mean temperature
of winter 2006-2007 in Greece (and worldwide) was
above average (warmest winter on record), and the
precipitation  drier  than  normal  (National
Observatory of Athens), conditions which might
have affected the prevalence of HBoV. 
Previous studies have implicated HBoV as a cause
of RTI, most commonly in children < 2 years old,
a finding similar to our study, where 10/12 children
were younger than 2 years, the youngest one being
a 2-month boy with acute bronchiolitis [13, 14, 
20-22]. However, frequency of HBoV infection was
found to be relatively low in children younger than
6 months, and the possibility of passive protection
due to maternal antibodies has been questioned.
These findings together with the high prevalence
rates in young children led to the hypothesis that
HBoV may be an endemic virus with high attack
rates in those susceptible; one would then expect
that  the  majority  of  the  population  would  be
infected  during  childhood.  In  support  of  this
hypothesis are the high seroprevalence rates against
HBoV reported in the adult population [23]. The mere
presence of HBoV in the airway may not be able to
define  its  role  as  a pathogen;  therefore  it  is
anticipated  that  serology  would  be  a useful
diagnostic addition to the study of HBoV infection.
Four of the 12 cases were co-infections, 3 of them
with influenza A virus and 1 with coronavirus OC43.
Similar findings were reported in other studies,
where  co-infection  was  found  in  one  third  of
patients [5, 24], while other investigators have
reported even higher rates [8, 15, 25]. It has been
hypothesized that detection of HBoV asymptomatic
presence  may  be  enhanced  by  the  symptoms
caused by another virus or that HBoV may aggravate
the clinical course of symptoms due to other viral
infections,  so  that  it  is  frequently  detected  in
hospitalized children [26]. Co-infection is frequently
described with many respiratory viruses and the
question whether this may result in more serious
clinical outcomes has not been clarified [27].
The association of HBoV with acute wheezing,
a symptom found in 62.5% of our patients, has been
well described in recently published studies [5, 14,
18, 28]. Another 2 of our patients presented with
laryngotracheobronchitis, a finding which is in
accordance with the study of Rihkanen et al. [29].
Only 1 of our patients returned for follow-up and
a second throat swab sample, taken 20 days after
the first one, was found negative for HBoV DNA. Our
findings suggest that HBoV may have similar clinical
features to those of other respiratory viruses such
as RSV. One may argue that the fact that HBoV is
prevalent in samples from patients with respiratory
tract infection does not guarantee a causative role
for the symptoms, especially when – as in this case
– it is frequently detected in combination with other
respiratory viruses of known pathogenic potential.
On the other hand, HBoV was rarely detected in
asymptomatic children [16, 22].
In conclusion, in the present study we have
provided a first insight into the epidemiology and
clinical aspects of HBoV infections in hospitalized
children in Greece. Our findings suggest a possible
association of HBoV with lower RTI, manifested
mainly by fever, cough and wheezing, most often
in infants, and a seasonal pattern with HBoV cases
occurring in cold months. 
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